top of page

Search


The new protein calculus: How Asia is rewriting the rules of satiety, fibre and flavour
Forget chalky shakes. Asia’s food technologists are bottling clarity and crystallising fibre. Our correspondent examines the continent’s quiet revolution in satiety science—and what it means for global portfolios.

Dr. TiehKoun Koh
Aug 185 min read


The Nostalgia Economy: Why Gen Z Is Buying Products from Eras They Never Lived Through — and What It Means for Your Brand
The Nostalgia Economy is now worth hundreds of billions globally—and Gen Z is leading the charge. But unlike older generations, Gen Z isn't buying history; they're buying escape. From Y2K aesthetics to analog tech, they're drawn to eras that feel simpler, slower, and more grounded than today's digital-saturated world. This blog explores why "fauxstalgia" is reshaping consumer behavior and how your brand can authentically tap into this trend without alienating your core audien

Dr. TiehKoun Koh
Aug 46 min read


The Double-Edged Helix: Data Protection and AI in Modern DNA Analysis
Can AI protect our most sensitive data? Explore the privacy challenges of AI-driven genomics and how federated learning, encryption & synthetic data are securing the future.

Dr. TiehKoun Koh
Jul 215 min read


From Lab to Global Leader: Navigating the Biotech Ingredient Lifecycle
Biotech food startups fail in the commercialisation gap—not in the lab. Our guide covers fundraising, SFA strategy, and scaling resilience for global markets.

Dr. TiehKoun Koh
Jun 227 min read


Midnight Football, Creaky Knees, and the Art of Staying Up (Without Falling Apart)
3 a.m. World Cup kickoffs, tired knees, and strained eyes. Science-backed rituals for fans who refuse to miss a goal.

Dr. TiehKoun Koh
Jun 104 min read


Cell & Gene Therapy Manufacturing Bottlenecks 2025: Investment Strategies in CDMOs, Viral Vector Capacity, and Regulatory Fast-Track Winners
Cell and gene therapy (CGT) has entered a new era. The FDA approved seven new cell and gene therapies in 2024–2025, including Abeona’s ZEVASKYN and Novartis’s ITVISMA. These curative treatments are no longer science fiction – they are reaching patients.
But here is the problem that smart investors are watching closely: manufacturing is failing.

Dr. TiehKoun Koh
May 283 min read


Beyond the Spots: The Business of Vision Preservation in a Digital Age
Latest 2025 research on eye floaters prevention: oxidative stress, supplements, and anti-aging. Essential reading for health and wellness business leaders.

Dr. TiehKoun Koh
May 215 min read


The Science of Mobility: New Frontiers in Joint Health and the Business of Movement
The Science of Mobility: 2026 Joint Health Research & Market Trends | NY Kingfisher Associates

Dr. TiehKoun Koh
Mar 168 min read


The New Science of Vitamins: Rethinking Supplements in the Modern Wellness Paradigm
Latest research debunks blanket vitamin use. Discover the power of food synergy, holistic wellness alternatives, and a new, targeted protoco

Dr. TiehKoun Koh
Dec 30, 20254 min read


Enhance Your Sales with B2B Workshops
https://www.nykingfisherassociates.com Sales growth is not a mystery. It’s a formula. A formula that demands action, precision, and the...

Dr. TiehKoun Koh
Sep 15, 20253 min read


The Convergence of Science and Innovation: A Tribute to Scientific Excellence and Strategic Collaboration
How to collaborate between universities and businesses have accelerated significantly in recent years, particularly in innovation, technology transfer, strategy, and policy deployment . These elements spark growth in knowledge-based economies and are increasingly important in both developed and developing countries. From the corporate perspective, partnerships with academic institutions provide access to novel ideas, technologies, and methodologies that might otherwise remain

Dr. TiehKoun Koh
Sep 6, 20258 min read


The Mind-Gut Axis: Unlocking a Billion-Dollar Opportunity in Nutritional Mental Health
Explore the compelling link between nutrition and mental wellness and the vast business opportunities it presents. NY Kingfisher Associates

Dr. TiehKoun Koh
Sep 1, 20254 min read


The Defensible Moats of Microbiome Investing: A Strategic Guide to Probiotics, Prebiotics and Postbiotics
For VCs: Gut health is a $85B+ market, but where is the defensible IP? NY Kingfisher Associates analyzes the investment landscape, highlight

Dr. TiehKoun Koh
Aug 26, 20255 min read


Account-Based Marketing Plan for Food and Nutrition Ingredients and Active Pharmaceutical Companies
How to write an effective strategic Account Based Marketing Plan

Dr. TiehKoun Koh
Aug 4, 20253 min read


Strategic Appetite: Leadership Lessons from 2025’s Food & Biotech M&A Frenzy
Leadership lessons takeaway in year 2025 M&A with interest in Food and Biotech industries.

Dr. TiehKoun Koh
Jul 30, 20255 min read



Dr. TiehKoun Koh
Jul 19, 20254 min read


Unlocking Growth: Hydrocolloids and Cyclodextrins Market Opportunities
The market opportunities for hydocolloids and cyclodextrin

Dr. TiehKoun Koh
Jun 20, 20252 min read


Drive Success in High Tech Industry with NY Kingfisher Associates
High technology business strategy

Dr. TiehKoun Koh
Apr 10, 20251 min read
bottom of page